3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine

C120H118Br5N45O4S — CID 159468950

IUPAC3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
SMILESCN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.CN(C)c1cccc(Nc2nc(Br)cn3c(-c4cccnc4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(-c4cccc(C(N)=O)c4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(Br)cnc23)c1.COc1nc(Br)cn2c(-c3ccc(N(C)C)cc3)cnc12.Cc1cnc2c(Nc3cccc(N(C)C)c3)nccn12.Cn1cc(-c2cnc3c(N)nccn23)cn1.Nc1nccn2c(Br)cnc12.Nc1nccn2ccnc12
InChIInChI=1S/C21H20N6O.C19H17BrN6.C15H15BrN4O.C15H17N5.C14H14BrN5O2S.C14H14BrN5.C10H10N6.C6H5BrN4.C6H6N4/c1-26(2)17-8-4-7-16(12-17)25-20-21-24-13-18(27(21)10-9-23-20)14-5-3-6-15(11-14)19(22)28;1-25(2)15-7-3-6-14(9-15)23-18-19-22-11-16(13-5-4-8-21-10-13)26(19)12-17(20)24-18;1-19(2)11-6-4-10(5-7-11)12-8-17-14-15(21-3)18-13(16)9-20(12)14;1-11-10-17-15-14(16-7-8-20(11)15)18-12-5-4-6-13(9-12)19(2)3;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-19(2)11-5-3-4-10(8-11)18-13-14-17-9-12(15)20(14)7-6-16-13;1-15-6-7(4-14-15)8-5-13-10-9(11)12-2-3-16(8)10;7-4-3-10-6-5(8)9-1-2-11(4)6;7-5-6-9-2-4-10(6)3-1-8-5/h3-13H,1-2H3,(H2,22,28)(H,23,25);3-12H,1-2H3,(H,23,24);4-9H,1-3H3;4-10H,1-3H3,(H,16,18);3-9H,1-2H3,(H,16,18);3-9H,1-2H3,(H,16,18);2-6H,1H3,(H2,11,12);1-3H,(H2,8,9);1-4H,(H2,7,8)
InChIKeyLVNWICDKHQAXFS-UHFFFAOYSA-N
MW2686.16 g/mol
LogP21.63
Rot. Bonds23

About 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine

3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine (PubChem CID 159468950) has the molecular formula C120H118Br5N45O4S and a molecular weight of 2686.16 g/mol. Its IUPAC name is 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine.

Molecular Properties

Compound Name3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
PubChem CID159468950
Molecular FormulaC120H118Br5N45O4S
Molecular Weight2686.16 g/mol
Exact Mass2679.61
IUPAC Name3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
SMILESCN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.CN(C)c1cccc(Nc2nc(Br)cn3c(-c4cccnc4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(-c4cccc(C(N)=O)c4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(Br)cnc23)c1.COc1nc(Br)cn2c(-c3ccc(N(C)C)cc3)cnc12.Cc1cnc2c(Nc3cccc(N(C)C)c3)nccn12.Cn1cc(-c2cnc3c(N)nccn23)cn1.Nc1nccn2c(Br)cnc12.Nc1nccn2ccnc12
InChIInChI=1S/C21H20N6O.C19H17BrN6.C15H15BrN4O.C15H17N5.C14H14BrN5O2S.C14H14BrN5.C10H10N6.C6H5BrN4.C6H6N4/c1-26(2)17-8-4-7-16(12-17)25-20-21-24-13-18(27(21)10-9-23-20)14-5-3-6-15(11-14)19(22)28;1-25(2)15-7-3-6-14(9-15)23-18-19-22-11-16(13-5-4-8-21-10-13)26(19)12-17(20)24-18;1-19(2)11-6-4-10(5-7-11)12-8-17-14-15(21-3)18-13(16)9-20(12)14;1-11-10-17-15-14(16-7-8-20(11)15)18-12-5-4-6-13(9-12)19(2)3;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-19(2)11-5-3-4-10(8-11)18-13-14-17-9-12(15)20(14)7-6-16-13;1-15-6-7(4-14-15)8-5-13-10-9(11)12-2-3-16(8)10;7-4-3-10-6-5(8)9-1-2-11(4)6;7-5-6-9-2-4-10(6)3-1-8-5/h3-13H,1-2H3,(H2,22,28)(H,23,25);3-12H,1-2H3,(H,23,24);4-9H,1-3H3;4-10H,1-3H3,(H,16,18);3-9H,1-2H3,(H,16,18);3-9H,1-2H3,(H,16,18);2-6H,1H3,(H2,11,12);1-3H,(H2,8,9);1-4H,(H2,7,8)
InChIKeyLVNWICDKHQAXFS-UHFFFAOYSA-N
XLogP21.63
TPSA546.53 Ų
H-Bond Donors9
H-Bond Acceptors47
Rotatable Bonds23
Heavy Atoms175
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002686.16
LogP ≤ 521.63
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1047

Analyze 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine
CID 157113903
4-[8-[4-(2-cyclohexylacetyl)anilino]imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one;4-[8-[4-[2-(1,2,2,6,6-pentamethylpiperidin-4-yl)acetyl]anilino]imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one;4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]-N-pyrrolidin-3-ylbenzenesulfonamide
CID 157368399
N-cyclohexyl-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N-cyclopentyl-4-[[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzenesulfonamide;N-[1-(4-fluorophenyl)cyclopropyl]-4-[[5-(2-oxo-1H-pyridin-4-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;4-[8-[4-(morpholin-4-ylmethyl)anilino]imidazo[1,2-a]pyridin-5-yl]-1H-pyridin-2-one
CID 157522905
3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
CID 157558514
N,N-dimethyl-4-[[5-(1-oxo-2,3-dihydroisoindol-5-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzamide;N,N-dimethyl-4-[[5-(1-oxo-2,3-dihydroisoindol-5-yl)imidazo[1,2-a]pyridin-8-yl]amino]benzenesulfonamide;5-[8-(4-morpholin-4-ylanilino)imidazo[1,2-a]pyridin-5-yl]-2,3-dihydroisoindol-1-one
CID 159206619
3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;methane;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
CID 160018342
5-(4-isocyanophenyl)-2-(5-methyl-3-pyridinyl)-N-(pyridin-2-ylmethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine;2-(5-methyl-3-pyridinyl)-5-(4-morpholin-4-ylphenyl)-N-(pyridin-2-ylmethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine;5-[5-phenyl-4-(pyridazin-3-ylmethylamino)pyrrolo[2,1-f][1,2,4]triazin-2-yl]pyridine-3-sulfonamide;1-[3-[5-phenyl-4-(pyridin-2-ylmethylamino)pyrrolo[2,1-f][1,2,4]triazin-2-yl]phenyl]ethanone
CID 160048185

Frequently Asked Questions

What is the IUPAC name of 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
The IUPAC name of 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine (CID 159468950) is 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine.
What is the SMILES notation for 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
The canonical SMILES for 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine is CN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.CN(C)c1cccc(Nc2nc(Br)cn3c(-c4cccnc4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(-c4cccc(C(N)=O)c4)cnc23)c1.CN(C)c1cccc(Nc2nccn3c(Br)cnc23)c1.COc1nc(Br)cn2c(-c3ccc(N(C)C)cc3)cnc12.Cc1cnc2c(Nc3cccc(N(C)C)c3)nccn12.Cn1cc(-c2cnc3c(N)nccn23)cn1.Nc1nccn2c(Br)cnc12.Nc1nccn2ccnc12.
What is the InChIKey of 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
The InChIKey is LVNWICDKHQAXFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20N6O.C19H17BrN6.C15H15BrN4O.C15H17N5.C14H14BrN5O2S.C14H14BrN5.C10H10N6.C6H5BrN4.C6H6N4/c1-26(2)17-8-4-7-16(12-17)25-20-21-24-13-18(27(21)10-9-23-20)14-5-3-6-15(11-14)19(22)28;1-25(2)15-7-3-6-14(9-15)23-18-19-22-11-16(13-5-4-8-21-10-13)26(19)12-17(20)24-18;1-19(2)11-6-4-10(5-7-11)12-8-17-14-15(21-3)18-13(16)9-20(12)14;1-11-10-17-15-14(16-7-8-20(11)15)18-12-5-4-6-13(9-12)19(2)3;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-19(2)11-5-3-4-10(8-11)18-13-14-17-9-12(15)20(14)7-6-16-13;1-15-6-7(4-14-15)8-5-13-10-9(11)12-2-3-16(8)10;7-4-3-10-6-5(8)9-1-2-11(4)6;7-5-6-9-2-4-10(6)3-1-8-5/h3-13H,1-2H3,(H2,22,28)(H,23,25);3-12H,1-2H3,(H,23,24);4-9H,1-3H3;4-10H,1-3H3,(H,16,18);3-9H,1-2H3,(H,16,18);3-9H,1-2H3,(H,16,18);2-6H,1H3,(H2,11,12);1-3H,(H2,8,9);1-4H,(H2,7,8).
What are the key properties of 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine?
3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine has a molecular weight of 2686.16 g/mol, XLogP of 21.63, 23 rotatable bonds, 9 hydrogen bond donors, and 47 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;1-N-(3-bromoimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;4-(6-bromo-8-methoxyimidazo[1,2-a]pyrazin-3-yl)-N,N-dimethylaniline;1-N-(6-bromo-3-pyridin-3-ylimidazo[1,2-a]pyrazin-8-yl)-3-N,3-N-dimethylbenzene-1,3-diamine;3-[8-[3-(dimethylamino)anilino]imidazo[1,2-a]pyrazin-3-yl]benzamide;3-N,3-N-dimethyl-1-N-(3-methylimidazo[1,2-a]pyrazin-8-yl)benzene-1,3-diamine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine is sourced from PubChem (CID 159468950), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).